

[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI
[ Wed, Jan 22nd 2020
] - WOPRAI

[ Tue, Jan 21st 2020
] - WOPRAI
[ Tue, Jan 21st 2020
] - WOPRAI
[ Tue, Jan 21st 2020
] - WOPRAI
[ Tue, Jan 21st 2020
] - WOPRAI
[ Tue, Jan 21st 2020
] - WOPRAI
[ Tue, Jan 21st 2020
] - WOPRAI
[ Tue, Jan 21st 2020
] - WOPRAI
[ Tue, Jan 21st 2020
] - WOPRAI
Mani Foroohar Initiated (ARWR) at Sell and Held Target at $32 on, Jan 21st, 2020
Mani Foroohar of SVB Leerink, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Sell and Held Target at $32 on, Jan 21st, 2020.
Mani has made no other calls on ARWR in the last 4 months.
There are 5 other peers that have a rating on ARWR. Out of the 5 peers that are also analyzing ARWR, 2 agree with Mani's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Esther Rajavelu of "Oppenheimer" Initiated at Hold on, Friday, December 13th, 2019
- Elemer Piros of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $50 on, Tuesday, November 19th, 2019
These are the ratings of the 3 analyists that currently disagree with Mani
- Joel Beatty of "Baird" Upgraded from Hold to Buy and Increased Target to $70 on, Monday, November 25th, 2019
- Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $59 on, Wednesday, November 13th, 2019
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $45 on, Tuesday, October 22nd, 2019
Contributing Sources
Similar Stocks and Investing Articles
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 10th 2020
] - WOPRAI
[ Mon, Dec 16th 2019
] - WOPRAI
[ Mon, Nov 25th 2019
] - WOPRAI
[ Tue, Nov 19th 2019
] - WOPRAI
[ Thu, Oct 24th 2019
] - WOPRAI
[ Tue, Oct 22nd 2019
] - WOPRAI